Search companies

Live

Tuesday, 17 November 2026 · 582 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

JPMorgan Lifts CLINUVEL Voting Stake To Nearly 8%

CUV: $7.38 -2.77% · MC: $375M

JPMorgan Chase & Co. and its affiliates increased their relevant interest in CLINUVEL Pharmaceuticals to 7.96% from 6.53%. The notice includes securities lending and client-related interests, so the change should not be read simply as a share purchase.

Source announcements: 2026-11-17 08:27 to 2026-11-17 16:14 Sydney time
Story updated 2026-11-17 16:20 Sydney time
SourcesChange in substantial holdingChange in substantial holding - Updated
Comments